Alks stock earnings
Find the latest Alkermes plc (ALKS) stock quote, history, news and other vital information to help you with your stock trading and investing. ALKS: Alkermes plc - Earnings News & Analysis - Zacks ... ALKS: Alkermes plc - Earnings Announcements. Stay up to date with lastest Earnings Announcements for Alkermes plc from Zacks Investment Research virtually every single Zacks Ranked stock. It's Alkermes - ALKS - Stock Price & News | The Motley Fool Real time Alkermes (ALKS) stock price quote, stock graph, The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. ALKS earnings call for the ALKS Stock Price, Forecast & News (Alkermes) | MarketBeat Alkermes' stock was trading at $16.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ALKS stock has decreased by 15.0% and is now trading at $13.81. View which …
News & Analysis: Alkermes. The Fool has written over 100 articles on Alkermes. All · Market Moves · Earnings.
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. ALKS Stock News - Fidelity Mar 27, 2020 · DUBLIN, March 4, 2020 Alkermes plc (ALKS) today announced the publication of results from the phase 3 ENLIGHTEN-1 clinical trial of ALKS 3831 in the peer-reviewed publication, Journal of Clinical Psychiatry.ENLIGHTEN-1 was a four-week study evaluating the efficacy, safety and tolerability of ALKS 3831 compared to placebo in 403 patients experiencing an acute … ALKS Stock Rating and Data | Alkermes PLC - GuruFocus.com ALKS stock rating and analysis - Alkermes PLC : a summary of key financial strength and profitability metrics. Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial
Nov 07, 2019 · ALKS, Alkermes Plc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines
Earnings Whisper Number for ALKS: Alkermes Plc
ALKS Stock Summary. Alkermes plc's stock had its IPO on July 16, 1991, making it an older stock than 82.96% of US equities in our set. Price to trailing twelve month operating cash flow for ALKS is currently 30.78, higher than 92% of US stocks with positive operating cash flow.
Find stock price reaction to earnings announcements for Alkermes PLC - (ALKS). Table displays both upcoming quarterly earnings dates and historical release dates as well as stock price changes, if available. For stocks that list options, compare implied volatility before and after earnings dates, as well as the option market's expected versus actual price movement. Alkermes plc > Investor Relations > Investor Events Corporate Overview Press Releases Investor Events Stock Information SEC Filings Annual Reports. Financials Snapshot Trading Statistics. Other Information Q4 2019 Alkermes plc Earnings Conference Call. ALKS 4230: An Investigational Selective IL-2 Fusion Protein. ALKS:NASDAQ GS Stock Quote - Alkermes PLC - Bloomberg Markets Stock analysis for Alkermes PLC (ALKS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
View live ALKERMES PLC chart to track its stock's price action. Find market predictions, ALKS financials and market news.
Earnings Whisper Number for ALKS: Alkermes Plc Oct 23, 2019 · Alkermes Plc (ALKS) reports earnings on 5/14/2020. Shares are down 26.2% since reporting last quarter. The Earnings Whisper Score gives … Alkermes (ALKS) Q4 Earnings and Revenues Top Estimates Feb 13, 2020 · Alkermes (ALKS) delivered earnings and revenue surprises of 25.76% and 1.14%, respectively, for the quarter ended December 2019. Do the numbers hold clues to … Alkermes plc (ALKS) Earnings Report | Seeking Alpha Alkermes plc (ALKS) latest earnings report: revenue, EPS, surprise, history, news and analysis.
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. ALKS Stock News - Fidelity Mar 27, 2020 · DUBLIN, March 4, 2020 Alkermes plc (ALKS) today announced the publication of results from the phase 3 ENLIGHTEN-1 clinical trial of ALKS 3831 in the peer-reviewed publication, Journal of Clinical Psychiatry.ENLIGHTEN-1 was a four-week study evaluating the efficacy, safety and tolerability of ALKS 3831 compared to placebo in 403 patients experiencing an acute … ALKS Stock Rating and Data | Alkermes PLC - GuruFocus.com ALKS stock rating and analysis - Alkermes PLC : a summary of key financial strength and profitability metrics. Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial ALKS - Alkermes Plc Stock quote - CNNMoney.com